In developing strategies to contest the systematic efforts to dismantle progressive social and economic policies generated through decades of activism, it is important to understand how discursive frames that were significant in social justice organizing in the United States have come to be subjugated, delegitimated, or co-opted, and have lost their power for social justice activism. Using a materialist feminist approach, I first examine the processes of subjugation and explore how movement actors choose frames within bounded discursive fields that become (...) institutionalized, but lose critical feminist or progressive intent. I then discuss the delegitimation of a citizen’s right to government support and the co-optation of progressive movement frames by conservative groups. I conclude with a materialist feminist call to attend to the multiple institutions that contour the discursive field and the everyday practices of social movement organizations. This is a call for collective research, since no single case can attend to all of these dimensions and processes. (shrink)

Endocrine-disrupting chemicals have been identified as posing risks to reproductive health and may have intergenerational effects. However, responses to the potential harms they pose frequently rely on medicalised understandings of the body and normative gender identities. This article develops an intersectional feminist framework of intergenerational justice in response to the potential risks posed by endocrine-disrupting chemicals. We examine critiques of endocrine disruptors from feminist, critical disability and queer standpoints, and explore issues of race and class in exposures. We argue that (...) responding to the risks posed by endocrine disruptors such as brominated flame retardants (BFRs) and phthalates requires developing a theory of intergenerational justice that recognises relationality and transcorporeality, and that also recognises harm in terms of suffering, not in terms of difference. (shrink)

Research on the U.S. women’s movement has documented the difficulties of cross-racial work between White women and women of racial/ethnic minorities. Less understood is how racial/ethnic minorities do cross-racial work among themselves to construct a collective identity of “women of color” that encourages solidarity across race, class, and other statuses. Drawing on research from the reproductive justice movement, I examine how women of color organizations that strive for intersectional praxis negotiate sameness and difference. I identify two different logics at work (...) within women of color organizations: the first relies on a presumption of “same difference” that emphasizes similar experiences of gender and race oppression; the second accords greater recognition to the “difference-in-sameness” that structures constituents’ lived experiences. While the former can reproduce precisely those forms of silencing and exclusion that women of color organizations seek to challenge, the second remains a ongoing process. The article concludes that women of color organizations must strive continuously to actively negotiate, rather than assume, commonality if they are to avoid reproducing various forms of marginalization and inequality. (shrink)

Intersectionality has been adopted as the preferred term to refer to and to analyze multiple axes of oppression in feminist theory. However, less research examines if this term, and the political analyses it carries, has been adopted by women’s rights organizations in various contexts and to what effect. Drawing on interviews with activists working in a variety of women’s rights organizations in France and Canada, I show that intersectionality is only one of the repertoires that a women’s rights organization might (...) use to analyze the social experience and the political interests of women situated at the intersection of several axes of domination. I propose a typology of four repertoires that activists use to reflect on intersectionality and inclusiveness. Drawing on a quantitative and qualitative analysis of the interview data, I show that hegemonic repertoires about racial or religious identity in one national context shape the way activists and organizations understand intersectionality and its challenges. The identity of organizations, as well as their main function, also shape their understanding of intersectional issues. (shrink)

Claims to sisterhood are premised on women’s experiences with gender oppression, and many have argued that such claims ignore differences among women. Many have therefore dismissed sisterhood as a legitimate claim to solidarity, failing to examine the ways that sisterhood continues to be utilized by feminist activists. This article examines qualitative data from a study of a white, middle-class, feminist, antiracist organization that uses the language of sisterhood in its work on behalf of incarcerated women, who are predominantly of color (...) and poor. The author finds not only that sisterhood is simultaneously rooted in women’s experiences with oppression and pride and pleasure but that such language serves complex functions in feminist organizations that seek to work across difference. Beyond its use in creating and sustaining solidarity, sisterhood is utilized to bridge differences in race, class, and life experiences between women and to generate feelings of legitimacy amongst white, middle-class activists. (shrink)

Critics of transnational commercial surrogacy frequently call our attention to the race, class, and cultural background of surrogates in the global South. Consider the following sampling from the critics: "the women having babies for rich Westerners have been pimped by their husbands and are powerless to resist" (Bindel 2011); our "rules of decency seem to differ when the women in question are living in abject poverty half a world away" (Warner 2008); and we should worry that "women of color are (...) easier to commodify" (Smerdon 2008, 51-52). Critics suggest—rightly, in my view—that the race, class, and culture of Southern surrogates matter to the moral acceptability of transnational surrogacy. But how, precisely, do .. (shrink)

The debate over abortion tends to be framed as life versus choice. Yet, neither pole matches the actual experiences of women, especially women of colour and poor women. Using the hermeneutical circle from the perspective of Christian liberation theology, this article argues that beginning with the voices of those marginalized in the debate leads us to a broader conversation of reproductive justice, which requires an analysis of reproduction as a whole. The article focuses on what constrains the ability of women (...) and men to choose whether to have children, across the spectrum from contraception to abortion to fetus selection. (shrink)

The US Food and Drug Administration (FDA) is fraught with controversies over the role of values and politics in regulatory science, especially with drugs in the realm of reproductive health. Philosophers and science studies scholars have investigated the ways in which social context shapes medical knowledge through value judgments, and feminist scholars and activists have criticized sexism and injustice in reproductive medicine. Nonetheless, there has been no systematic study of values and gender norms in FDA drug regulation. I focus on (...) three questions about values in regulatory science. First, how have societal values and gender norms shaped the way that the FDA regulates drugs in the realm of reproductive health, specifically with drug labels? Second, what are the ethical, epistemic, and social consequences of these influences on regulation for women and other marginalized groups? Third, which societal values and gender norms ought to influence drug regulation about reproductive health, and how ought this happen? Integrating philosophical analysis with historical archival research and in-depth interviews, I conduct three case studies of drug labeling about reproductive health: (1) the “drug fact” about the mechanism of the morning-after pill; (2) the package inserts for patients about the health risks of oral contraceptives; and (3) the special physician labels made for prescribing drugs to pregnant women. I identify three challenges for the FDA and suggest ways to reduce the influence of sexist values and facilitate feminist alternatives. First, across these cases, I have found that there are many ways in which other concerns in reproductive medicine (such as zygotic life, fetal health, and population control) have devalued women’s health. Second, both knowledge and ignorance xvi about their reproductive health have contributed to women’s oppression, especially poor women and women of color. Finally, by avoiding the epistemic dimensions of ethics, powerful, mostly male parties in medicine (such as doctors, pharmaceutical companies, and religious institutions) have misused “informed consent,” “religious freedom,” and “paternalism” for unethical purposes. For improvement, I suggest extracting sexist values and gender norms from regulatory science that cause epistemic injustices, and I point to success stories for reforming sexism with feminism at the FDA. (shrink)